Serina Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire • Sep 10, 2026
Read articleSerina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2
GlobeNewswire • Sep 9, 2026
Read articleSerina Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
GlobeNewswire • Aug 13, 2026
Read articleSerina Therapeutics to Participate in the BTIG Virtual Biotechnology Conference
GlobeNewswire • Jul 24, 2026
Read articleSerina Completes Enrollment, Dosing in First Cohort of Phase 1b Trial in Parkinson's Disease
MT Newswires • Jul 23, 2026
Read articleSerina Therapeutics Announces Completion of Enrollment and Dosing in Cohort 1 of Registrational Trial of SER-252 for Advanced Parkinson’s Disease
GlobeNewswire • Jul 23, 2026
Read article